Kornitzer Capital Management Inc Amgen Inc Transaction History

Kornitzer Capital Management Inc

$4.65 Billion
Q1 2025

A detailed history of Kornitzer Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 15,242 shares of AMGN stock, worth $4.24 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

15,242

Previous 15,340 0.64%

Holding current value

$4.24 Million

Previous $4 Million 18.76%

% of portfolio

0.1%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$258.59 - $327.36 $25,341 - $32,081	-98 Reduced 0.64%	15,242 $4.75 Million
Q4 2024 Jan 31, 2025	SELL	$258.78 - $328.31 $19,926 - $25,279	-77 Reduced 0.5%	15,340 $4 Million
Q3 2024 Oct 31, 2024	SELL	$309.38 - $337.38 $398,481 - $434,545	-1,288 Reduced 7.71%	15,417 $4.97 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $126,120 - $153,268	480 Added 2.96%	16,705 $5.22 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $23,122 - $27,912	86 Added 0.53%	16,225 $4.61 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $239,846 - $270,575	-938 Reduced 5.49%	16,139 $4.65 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $67,125 - $83,338	307 Added 1.83%	17,077 $4.59 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $26,998 - $31,924	126 Added 0.76%	16,770 $3.72 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $46,286 - $56,416	205 Added 1.25%	16,644 $4.02 Million
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $75,350 - $95,742	329 Added 2.04%	16,439 $4.32 Million
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $22,446 - $25,315	-100 Reduced 0.62%	16,110 $3.63 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $102,665 - $114,249	445 Added 2.82%	16,210 $3.94 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $1.07 Million - $1.19 Million	-4,890 Reduced 23.67%	15,765 $3.81 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $156,120 - $178,666	-785 Reduced 3.66%	20,655 $4.65 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $21,227 - $24,870	-100 Reduced 0.46%	21,440 $4.56 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 0.23%	21,540 $5.36 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $952,072 - $1.13 Million	-4,400 Reduced 16.93%	21,590 $4.96 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $175,987 - $195,712	-750 Reduced 2.8%	25,990 $6.61 Million
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $14,835 - $18,205	75 Added 0.28%	26,740 $6.31 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $337,144 - $447,145	-1,850 Reduced 6.49%	26,665 $5.41 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $1.53 Million - $1.97 Million	-8,100 Reduced 22.12%	28,515 $6.87 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $38,304 - $45,896	220 Added 0.6%	36,615 $7.09 Million
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $36,174 - $40,776	200 Added 0.55%	36,395 $6.91 Million
Q4 2018 Jan 31, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 0.28%	36,195 $7.05 Million
Q2 2018 Aug 02, 2018	BUY	$166.05 - $186.51 $12,453 - $13,988	75 Added 0.21%	36,295 $6.7 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $37,274 - $43,560	-220 Reduced 0.6%	36,220 $6.18 Million
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $316,481 - $353,606	-1,875 Reduced 4.89%	36,440 $6.34 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $6.41 Million - $7.32 Million	38,315	38,315 $7.14 Million

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Amgen Inc Transaction History